File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation

TitleCase Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation
Authors
Keywordscontinuous glucose monitoring
endoscopic ultrasound
insulinoma
radio frequency ablation
type 2 diabetes
Issue Date2022
Citation
Frontiers in Endocrinology, 2022, v. 13, article no. 957369 How to Cite?
AbstractThe coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential.
Persistent Identifierhttp://hdl.handle.net/10722/336942
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChang, Johnny Yau Cheung-
dc.contributor.authorWoo, Chariene Shao Lin-
dc.contributor.authorLui, David Tak Wai-
dc.contributor.authorFung, Matrix Man Him-
dc.contributor.authorLee, Alan Chun Hong-
dc.contributor.authorLeung, Eunice Ka Hong-
dc.contributor.authorWoo, Yu Cho-
dc.contributor.authorChow, Wing Sun-
dc.contributor.authorLam, Karen Siu Ling-
dc.contributor.authorTan, Kathryn Choon Beng-
dc.contributor.authorLee, Chi Ho-
dc.date.accessioned2024-02-29T06:57:36Z-
dc.date.available2024-02-29T06:57:36Z-
dc.date.issued2022-
dc.identifier.citationFrontiers in Endocrinology, 2022, v. 13, article no. 957369-
dc.identifier.urihttp://hdl.handle.net/10722/336942-
dc.description.abstractThe coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential.-
dc.languageeng-
dc.relation.ispartofFrontiers in Endocrinology-
dc.subjectcontinuous glucose monitoring-
dc.subjectendoscopic ultrasound-
dc.subjectinsulinoma-
dc.subjectradio frequency ablation-
dc.subjecttype 2 diabetes-
dc.titleCase Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.3389/fendo.2022.957369-
dc.identifier.scopuseid_2-s2.0-85135464654-
dc.identifier.volume13-
dc.identifier.spagearticle no. 957369-
dc.identifier.epagearticle no. 957369-
dc.identifier.eissn1664-2392-
dc.identifier.isiWOS:000837107900001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats